After 16 years, medical-cannabis patients in the state can finally buy pot from dispensaries. But there’s a lot of fine print.
HONOLULU, Hawaii—Aloha Green is situated in a downtown building whose austere beige-ness belies the company’s more therapeutic purpose: It’s a medical marijuana dispensary.
As soon as I tried to walk inside for an interview, I was met by a metal detector and a large man who demanded to see my medical marijuana card. I don’t have one—I don’t live in Hawaii and am not seeking the most herbal of cures for my ailments—so I’m told to wait outside. All I catch a glimpse of is a small window behind which some workers toil away quietly, like they’re at a bank.
Instead, I was lead upstairs to the dispensary’s office by Helen Cho, Aloha Green’s director. Printed out and wall-papering half the conference room was the entirety of Hawaii’s medical-marijuana legislation. They don’t want to miss a single, nit-picky detail.
And there are a lot of them. They can’t sell paraphernalia, like rolling papers, or edibles. Everything has to be grown indoors and tested before it can go out to customers. Shoppers can look at the bright green buds under a magnifying glass, but they’re forbidden from touching the product.
Hawaii in the late 70s was a land of artisanal home growers and farmers producing legendary strains like Maui Wowee and Puna Butter. Rolling Stone in 1979 called pakalolo Hawaii’s No. 1 crop, above sugar and pineapple. Its sickly-sweet haze hung heavily over concerts and beaches, and there was a remarkable tolerance in the air, too.
Medical cannabis was legalized here rather early, in 2000, but Aloha Green and other dispensaries only secured licenses in the past year or so. It took that long for the state to authorize dispensaries.
These regulations make the pot at Hawaii’s dispensaries more expensive than it is in places where marijuana flows freely and recreationally, like Colorado or Washington. (Customers can pay with cash or with CanPay, an app designed for cannabis retailers. Aloha Green doesn’t take regular credit cards.)
Cho, who doesn’t use cannabis herself, seemed drawn to the cannabis industry by these challenges. She worked in start-ups in New York before moving here—apparently the only thing as tough as venture capital in the big city is operating a marijuana store in paradise.
Dispensaries here are regulated by the health department. Cho speculated, nicely, that their bureaucratic overseers might be, well, a little square. “They all have very good intentions, but because they are upright citizens who’ve not done bad things, they don’t really know about cannabis culture and the way that it works,” she said. “Understandably, they haven’t ventured into it, because they are good citizens who don’t break the law.”
She has the health department virtually on speed dial. On a given day she might ask them, for example, does posting a menu of available products violate the ban on advertising? “Right now we are trying to understand the language that’s in legislation for packaging,” she said. It’s not allowed to be attractive to children.
Franklin G. Snyder, a law professor at Texas A&M University, says that while nothing Hawaii is doing is especially unusual, the combination “makes it one of the strictest laws in the country.” The vertical integration rule might be there to prevent a big-tobacco-esque conglomerate from taking over the state’s marijuana market. Or it might make the industry easier to regulate. He predicts Hawaii might loosen its medical marijuana regulations after the first few dispensaries get off the ground.
“Given the general attitudes in Hawaii, once they get their feet wet, I think they will liberalize,” he said.
Kleiman, meanwhile, thinks medical marijuana is often just the first skid on the slippery slope to full legalization. “Why Hawaii hasn’t gone ahead and legalized marijuana, I don’t know,” he said.
There is, of course, the other possibility. Attorney General Jeff Sessions, who is notoriously anti-pot, might shut Aloha Green and other dispensaries down entirely by enforcing federal drug laws more rigorously. In case that day comes, Cho and her colleagues are making sure they’ve followed the law to the letter. It helps that several members of the dispensary’s executive team are lawyers.
“Everyone wants to just be sure that they are doing the right thing,” Cho said, “because at the end of the day, we are still dealing with a Schedule I drug.”
By Olga Khazan – The Atlantic
Photo Credit Mark Blinch / Reuters
